RxDoctor Payments Data

Vincent Ostrowski, MD

Otology & Neurotology · Indianapolis, INNPI 1861495533

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.8% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Cochlear Americas at 39.4% of the total.

$2,364in general payments, 2019–2025

Across 33 payments — averaging $71.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$932
  • Med-el Corporation$395
  • Oticon Medical, LLC$362
  • Integra Lifesciences Corporation$148
  • Grace Medical, Inc.$135
  • Advanced Bionics, LLC$129
  • plus $262 from 3 others

What the payments were for

  • Travel & lodging$1958%
  • Food & beverage$2,16992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$197,304
Medicare patients
1,021
Services billed
2,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin144$4,010
Ipratropium Bromide31$2,012
Azelastine Hcl27$1,489
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid121$713
Fluocinolone Acetonide Oil17$665
Cefdinir31$585
Potassium Chloride34$517
Fluticasone Propionate26$510
Nortriptyline Hcl30$493
Triamcinolone Acetonide161$383
Prednisone71$360
Diazepam75$340
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen64$340
Alprazolam OdtAlprazolam13$320
Spironolactone28$298

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →